Alseres Pharmaceuticals, Inc. Share - Company Data & Prices - US0211522026 | MoneyPeak

Alseres Pharmaceuticals, Inc.

Share · US0211522026 (OTC)

No Price

n/a

Company Profile for Alseres Pharmaceuticals, Inc. Share

Alseres Pharmaceuticals, Inc. focuses on developing diagnostic and therapeutic products primarily for disorders in the central nervous system. Its lead product candidate is Altropane, a molecular imaging agent for the diagnosis of Parkinson's disease and dementia. The company was formerly known as Boston Life Sciences, Inc. and changed its name to Alseres Pharmaceuticals, Inc. in June 2007. Alseres Pharmaceuticals, Inc. was founded in 1972 and is based in Auburndale, Massachusetts.

AI Analysis of Alseres Pharmaceuticals, Inc.

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of Alseres Pharmaceuticals, Inc.

No AI threads available for this company yet.

Company Data

Name Alseres Pharmaceuticals, Inc.

Company Alseres Pharmaceuticals, Inc.

Website https://www.alseres.com

Primary Exchange

UTC

ISIN US0211522026

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Peter G. Savas

Country United States of America

Currency USD

Employees 0,0 T

Address 275 Grove Street, 02466 Auburndale

IPO Date 1994-12-22

Ticker Symbols

Name	Symbol
Over The Counter	ALSE

More Shares

Investors who hold Alseres Pharmaceuticals, Inc. also have the following shares in their portfolio:

GYRE THERAPEUTICS Share

Ten Allied Co.,Ltd. Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2026